-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $19

Benzinga·11/16/2026 13:39:34
Listen to the news
B. Riley Securities analyst Madison El-Saadi reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $18 to $19.